AI brief of an SEC Form 8-K · Zimmer Biomet (ZBH)

Zimmer Biomet issues $1.75 billion in notes due 2027, 2030 and 2035

Neutral Impact 3 of 5 financing Written later

Zimmer Biomet completed the issuance of $600 million of 4.700% notes due 2027, $550 million of 5.050% notes due 2030 and $600 million of 5.500% notes due 2035, adding $1.75 billion of direct debt. The 2030 and 2035 notes must be redeemed at 101% of principal, plus accrued interest, if the pending Paragon 28 acquisition is not completed on time or is terminated, so their repayment depends on that deal.

Key points

  • The 2027 notes mature February 19, 2027, the 2030 notes February 19, 2030 and the 2035 notes February 19, 2035.
  • Interest is payable semi-annually on February 19 and August 19, starting August 19, 2025.
  • The 2030 and 2035 notes carry a special mandatory redemption at 101% of principal if the Paragon 28 merger is not completed by November 28, 2025 (extendable to January 28, 2026) or the merger agreement is terminated.
  • The notes were issued under a Twelfth Supplemental Indenture dated February 19, 2025, to a base indenture dated November 17, 2009, with Computershare Trust Company, N.A. as trustee.

The filing

CompanyZimmer Biomet (ZBH)
Form8-K, current report
Filed with the SECFeb 19, 2025, 4:16 PM ET
Accession number0001193125-25-029614

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 7:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 19, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.